Results 131 to 140 of about 2,419 (196)

An Insight Into the Aerosolization Pattern of Formoterol Fumarate Dry Powder Inhalation Formulation Actuated Via Two Different Inhaler Devices. [PDF]

Adv Pharm Bull
Asadollahi L, Ghanbari R, Abbaspour-Ravasjani S, Hamishehkar H, Nokhodchi A.   +4 more
europepmc   +1 more source

Correction to: Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/ Formoterol Fumarate in General Practice in England. [PDF]

Adv Ther
Woodcock A, Blakey J, Bourdin A, Canonica GW, Domingo C, Ford A, Hulme R, Tritton T, Palomares I, Sadhu S, Biswas A, Verma M.   +11 more
europepmc   +1 more source

A simple and rapid procedure for the determination of the urinary concentration of formoterol by LC-MS/MS

, 2012
Formoterol is included in the World Anti-Doping Agency list of prohibited substances and methods. In 2012 a threshold of 30 ng/mL was established to differentiate between the prohibited oral and the permitted inhalatory administration.
S. Turi, I. Fiacco, BOTRE', Francesco, M. Mazzarino   +3 more
core  

Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma. [PDF]

Adv Respir Med
Maiorano A, Ferrante Bannera A, Lupia C, Pastore D, Chiarella E, Piazzetta GL, Maglio A, Vatrella A, Pelaia G, Pelaia C.   +9 more
europepmc   +1 more source

Real-Life Efficacy of Single-Inhaler Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate in Persistent COPD Users: A Retrospective Database Study. [PDF]

Biomedicines
Sposato B, Lacerenza LG, Croce S, Petrucci E, Fabbrini V, Giannini L, Baratta P, Cresti A, Ricci A, Micheletto C, Perrella A, Alonzi V, Serafini A, Scalese M.   +13 more
europepmc   +1 more source

Assessment of Symptoms Control, Pulmonary Function and Related Quality of Life in Asthmatic Patients Treated with Extrafine Beclomethasone Dipropionate/Formoterol Fumarate 100/6 μg pMDI: Results of a Multicenter Observational Study in Romania (ALFRESCO Study). [PDF]

J Asthma Allergy, 2022
Ulmeanu R, Bloju S, Vittos O.
europepmc   +1 more source

Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/Formoterol Fumarate in General Practice in England. [PDF]

Adv Ther
Woodcock A, Blakey J, Bourdin A, Canonica GW, Domingo C, Ford A, Hulme R, Tritton T, Palomares I, Sadhu S, Biswas A, Verma M.   +11 more
europepmc   +1 more source

Budesonide/glycopyrronium/formoterol fumarate co-suspension metered dose inhaler relieves cough after lobectomy: a randomized controlled study. [PDF]

Transl Lung Cancer Res
Dong J, Jiang S, Qiu Y, Li J, Cui F, Liang H, Lao S, Xie Z, Huang J, Hao Z, He H, Xv X, Zhang M, He M, Zhang Y, He J, Wang W.   +16 more
europepmc   +1 more source

Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis. [PDF]

Adv Ther, 2021
Bourdin A, Molinari N, Ferguson GT, Singh B, Siddiqui MK, Holmgren U, Ouwens M, Jenkins M, De Nigris E.   +8 more
europepmc   +1 more source

Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised controlled trial. [PDF]

Respir Res
Watz H, Kirsten AM, Ludwig-Sengpiel A, Krüll M, Mroz RM, Georges G, Varoli G, Charretier R, Cortellini M, Vele A, Galkin D.   +10 more
europepmc   +1 more source